Monatepil maleate

CAS No. 103379-03-9

Monatepil maleate( —— )

Catalog No. M34105 CAS No. 103379-03-9

Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Monatepil maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity.
  • Description
    Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity.Monatepil maleate is used in studies of hyperlipidemia and atherosclerosis. Monatepil maleate is used to study hyperlipidemia and atherosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Acyltransferase | Calcium Channel | Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103379-03-9
  • Formula Weight
    591.69
  • Molecular Formula
    C32H34FN3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C\C(O)=O)\C(O)=O.N(C(CCCN1CCN(CC1)C2=CC=C(F)C=C2)=O)C3C=4C(CSC=5C3=CC=CC5)=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • RBN013209

    RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.

  • Ganoderic acid C6

    Ganoderic acid C6 has antinociceptive activity.

  • Levistilide A

    Levistilide A inhibits liver fibrosis and angiogenesis.